

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.45%
+0.91%
+4.04%
+0.96%
-2.22%
AZN
Astrazeneca
$83.40
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Chart
$73.76 (+13.07%)
$75.2 (+10.90%)
$71.82 (+16.12%)
$63.85 (+30.62%)
AZN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

AZN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
AZN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
AZN Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayAZN Earnings
The TTM reflects 12-month period, providing review of AZN financial performance.
The company financial health has moderately improved over the past year
Financial Score
NVS
131.64
+0.15%
PFE
24.67
-0.22%
MRK
87.18
-0.55%
SNY
49.52
-0.94%
TEVA
19.02
+0.37%
What is AZN current stock price?
What are AZN stock strengths?
What risks are associated with AZN stock?
When is AZN next earnings report?
What is AZN market cap and volume?
What is AZN's current Stock IQ?
Should I buy AZN stock right now?
Is AZN a Strong Buy right now?
What does a 'Strong Buy' rating mean for AZN?
What does a 'Strong Sell' rating mean for AZN?
What factors influence AZN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.45%
+0.91%
+4.04%
+0.96%
-2.22%
AZN
Astrazeneca
Current Price
$83.40
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Linked to AZN
NVS
131.64
+0.15%
PFE
24.67
-0.22%
MRK
87.18
-0.55%
SNY
49.52
-0.94%
TEVA
19.02
+0.37%
Chart
$73.76 (+13.07%)
$75.2 (+10.90%)
$71.82 (+16.12%)
$63.85 (+30.62%)
AZN Analysts Opinion
AZN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
AZN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
AZN Street view is extremely bullish and have positive views on the near-term outlook
AZN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
AZN Earnings
The TTM data reflects the most recent 12-month period, providing overview of AZN financial performance.
AZN Financial Health
The company financial health has moderately improved over the past year
Financial Score
AZN Latest Analysis
Berenberg Bank Reiterates AstraZeneca PLC - Depositary Receipt (AZN) Buy Recommendation. Fintel reports that on October 21 2025 Berenberg Bank reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Buy recommendation. Analyst Price Forecast Suggests 8.37% Upside
Thu Oct 23, 2025
Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug AstraZeneca Partnership.
Thu Oct 23, 2025
J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN) Sets a £140 PT. AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to buy right now. AstraZeneca PLC (NASDAQ:AZN) received a rating update from J.P. Morgan analyst Richard Vosser on October 20 who assigned the stock a Buy rating with a £140 price target. The rating update followed AstraZeneca PLCs (NASDAQ:AZN) announcement of positive results [….]
Thu Oct 23, 2025
AstraZeneca PLC (AZN) Presents at ESMO Congress 2025 - Slideshow.
Tue Oct 21, 2025
Heres Why Astrazeneca (AZN) is a Strong Momentum Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Mon Oct 20, 2025
AstraZenecas Imfinzi Improves Disease-Free Survival In Early-Stage Bladder Cancer . (RTTNews) - AstraZeneca (AZN) Friday announced positive Phase III results from its POTOMAC trial showing that adding one year of treatment with Imfinzi. durvalumab to standard BCG therapy significantly improved disease-free survival in patients with BCG-naï.ve high-risk non-mus
Fri Oct 17, 2025
AstraZeneca reports positive data from Imfinzis bladder cancer trial.
Fri Oct 17, 2025
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades. Key PointsEli Lilly and AstraZeneca are two of the most promising stocks in healthcare.
Thu Oct 16, 2025
Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Tue Oct 14, 2025
JP Morgan Cazenove Reiterates AstraZeneca PLC - Depositary Receipt (AZN) Overweight Recommendation. Fintel reports that on October 13 2025 JP Morgan Cazenove reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Overweight recommendation. Analyst Price Forecast Suggests 6.99% Upside
Tue Oct 14, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.